PEOPLE - Baxter makes appointment:
This article was originally published in Clinica
Executive Summary
The president of US company Baxter, Harry Jansen Kraemer, has been named as its CEO, effective December 31 1998. He will replace Vernon Loucks who will remain as chairman of Baxter's board of directors. William Kilgallon has been promoted to director of global marketing, peritoneal dialysis solutions, for Baxter Healthcare. He was previously director of European marketing of PD solutions.
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.